共 53 条
[1]
Christopher G.W., Cieslak T.J., Pavlin J.A., Et al., Biological warfare. A historical perspective, JAMA, 278, pp. 412-417, (1997)
[2]
Franz D.R., Jahrling P.B., Friedlander A.M., Et al., Clinical recognition and management of patients exposed to biological warfare agents, JAMA, 278, pp. 399-411, (1997)
[3]
Cieslak T.J., Eitzen E.M., Clinical and epidemiologic principles of anthrax, Emerg Infect Dis, 5, pp. 552-555, (1999)
[4]
Health Aspects of Chemical and Biological Weapons, pp. 97-99, (1970)
[5]
Simon J.D., Biological terrorism: preparing to meet the threat, JAMA, 278, pp. 428-430, (1997)
[6]
Cole L.A., The specter of biological weapons, Sci Am, 275, pp. 60-65, (1996)
[7]
Inglesby T.V., Henderson D.A., Barlett J.G., Et al., Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense, JAMA, 281, pp. 1735-1745, (1999)
[8]
Dixon T.C., Meselson M., Guillemin J., Et al., Anthrax, N Engl J Med, 341, pp. 815-826, (1999)
[9]
Friedlander A., Welkos S.L., Pitt M.L., Et al., Postexposure prophylaxis against experimental inhalation anthrax, J Infect Dis, 167, pp. 1239-1242, (1993)
[10]
Meselson M., Guillemin J., Hugh-Jones M., Et al., The Sverdlovsk anthrax outbreak of 1979, Science, 266, pp. 1202-1208, (1994)